| Product type | SSPA 1230 Reverse Convertible, multi-barrier, issuer-callable, Quanto CHF (ISIN CH1593763399). |
|---|---|
| Underlyings | Bayer AG, Johnson & Johnson and Merck & Co. — payoff depends on the worst-performing of the three. |
| Coupon | 12.00% p.a., paid quarterly (CHF 30 per CHF 1,000 = 3.00% per quarter), paid regardless of underlying performance. |
| Term | 18 months (issue Aug 2026, final fixing Feb 2028). |
| Downside protection | 59% continuous barrier on each underlying (monitored on each underlying's exchange business day). Strike = 100% of initial fixing. |
| Upside | Capped — maximum payoff is par plus coupons (up to 18 index points). |
The investor receives a high quarterly coupon (3.00% per quarter) no matter what the three pharma stocks do. At maturity:
The issuer may call the product early at any of the four quarterly observation dates, returning par plus the coupon for that date.
| Metric | Structured Product | Underlying Basket (equal-weight, with dividends) |
|---|---|---|
| Expected annualized return | 6.89% | 13.44% |
| Expected annualized volatility | 11.76% | 21.63% |
| Probability of loss | 15.78% | 29.78% |
| 99% confidence VaR (1 year) | -32.24% | -24.87% |
| Expected total return over holding period | 6.20% | — |
Scatter plot of simulated outcome pairs across 10,000 paths.
Histograms of annualized returns for the underlying basket and the structured product.
Bar chart of outcome scenario probabilities.
Risk/return positioning of the structured product versus the underlying basket.
Box plot comparing the distribution of outcomes.
Distribution of realized holding periods and number of coupons received.